company background image
1110 logo

Kingworld Medicines Group Informe acción SEHK:1110

Último precio

HK$0.49

Capitalización de mercado

HK$290.6m

7D

2.1%

1Y

-35.5%

Actualizada

06 Nov, 2024

Datos

Finanzas de la empresa

Kingworld Medicines Group Limited

Informe acción SEHK:1110

Capitalización de mercado: HK$290.6m

Resumen de acción 1110

Kingworld Medicines Group Limited, sociedad de cartera de inversiones, se dedica principalmente a la distribución y venta de productos farmacéuticos y sanitarios importados de marca.

Análisis fundamental de 1110
Puntuación del snowflake
Valoración2/6
Crecimiento futuro0/6
Rendimiento pasado2/6
Salud financiera5/6
Dividendos4/6

Competidores de Kingworld Medicines Group Limited

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de Kingworld Medicines Group
Precios históricos de las acciones
Precio actual de la acciónHK$0.49
Máximo en las últimas 52 semanasHK$0.78
Mínimo de 52 semanasHK$0.48
Beta0.74
1Cambio en 1 mes-12.50%
Variación en 3 meses-5.77%
Cambio de 1 año-35.53%
3Variación en 3 años-35.53%
Variación en 5 años-44.32%
Variación desde la OPV-76.10%

Noticias y actualizaciones recientes

Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt

Oct 04
Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt

Recent updates

Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt

Oct 04
Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338

May 31
Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely

May 22
Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely

Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings

Apr 29
Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings

Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338

Apr 23
Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338

A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Mar 22
A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising

Nov 30
The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising

Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement

Aug 17
Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement

Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247

May 30
Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247

The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing

May 11
The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247

Apr 03
Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247

Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture

Feb 07
Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture

A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Oct 07
A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)

Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business

Jul 05
Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business

Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024

Apr 27
Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024

We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)

Aug 17
We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)

Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly

Apr 24
Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly

Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)

Mar 29
Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)

Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares

Mar 08
Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares

Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?

Feb 15
Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?

Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)

Jan 25
Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)

Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?

Dec 18
Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?

We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt

Dec 05
We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt

What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation

Nov 22
What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation

Rentabilidad de los accionistas

1110HK HealthcareMercado HK
7D2.1%1.3%1.6%
1Y-35.5%-22.1%16.8%

Rentabilidad vs. Industria: Los resultados de 1110 fueron inferiores a los de la industria Hong Kong Healthcare, que obtuvo un rendimiento del -21.6% el año pasado.

Rentabilidad vs. Mercado: 1110 obtuvo unos resultados inferiores a los del mercado Hong Kong, que fueron del 18.1% el año pasado.

Volatilidad de los precios

Is 1110's price volatile compared to industry and market?
1110 volatility
1110 Average Weekly Movement4.0%
Healthcare Industry Average Movement8.4%
Market Average Movement8.9%
10% most volatile stocks in HK Market19.0%
10% least volatile stocks in HK Market4.2%

Precio estable de las acciones: 1110 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de 1110 (4%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
1996927Li Sheng Zhaowww.kingworld.com.cn

Kingworld Medicines Group Limited, un holding de inversiones, se dedica principalmente a la distribución y venta de productos farmacéuticos y sanitarios importados de marca. La empresa ofrece productos para aliviar la tos, aliviar la flema, calmar el asma, mejorar el sistema respiratorio, facilitar la digestión, promover la salud intestinal, activar la circulación sanguínea, aliviar el dolor, combatir la gripe y otras categorías bajo las marcas Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, Kingworld Imada Red Flower Oil, la serie de productos probióticos Culturelle, los servicios de productos Lifeline Care y la serie de productos Mentholatum. También fabrica y vende dispositivos electroterapéuticos y fisioterapéuticos, así como dispositivos de reconocimiento médico general; y suministra productos farmacéuticos, sanitarios, alimenticios generales y médicos.

Resumen de fundamentos de Kingworld Medicines Group Limited

¿Cómo se comparan los beneficios e ingresos de Kingworld Medicines Group con su capitalización de mercado?
Estadísticas fundamentales de 1110
Capitalización bursátilHK$290.62m
Beneficios(TTM)HK$33.67m
Ingresos (TTM)HK$1.14b

8.6x

Ratio precio-beneficio (PE)

0.3x

Ratio precio-ventas (PS)

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de 1110
IngresosCN¥1.05b
Coste de los ingresosCN¥788.49m
Beneficio brutoCN¥263.24m
Otros gastosCN¥232.15m
BeneficiosCN¥31.09m

Últimos beneficios comunicados

Jun 30, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)0.052
Margen bruto25.03%
Margen de beneficio neto2.96%
Ratio deuda/patrimonio49.6%

¿Cómo se ha desempeñado 1110 a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

6.7%

Rentabilidad actual por dividendo

58%

Ratio de pagos